-
Je něco špatně v tomto záznamu ?
Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
M. Doubková, M. Karpíšek, J. Mazoch, J. Skřičková, M. Doubek,
Jazyk angličtina Země Itálie
Typ dokumentu srovnávací studie, hodnotící studie, časopisecké články
PubMed
27758987
Knihovny.cz E-zdroje
- MeSH
- biologické markery krev MeSH
- bronchoalveolární lavážní tekutina chemie MeSH
- chronická obstrukční plicní nemoc krev diagnóza mortalita MeSH
- diferenciální diagnóza MeSH
- dospělí MeSH
- faktor TFF3 krev MeSH
- idiopatická plicní fibróza krev diagnóza mortalita MeSH
- lidé MeSH
- multivariační analýza MeSH
- plíce diagnostické zobrazování metabolismus patofyziologie MeSH
- plicní sarkoidóza krev diagnóza mortalita MeSH
- počítačová rentgenová tomografie MeSH
- prediktivní hodnota testů MeSH
- prognóza MeSH
- protein A asociovaný s plicním surfaktantem krev MeSH
- protein D asociovaný s plicním surfaktantem krev MeSH
- proteiny S100 krev MeSH
- sekreční proteiny prostaty krev MeSH
- senioři MeSH
- spirometrie MeSH
- studie případů a kontrol MeSH
- stupeň závažnosti nemoci MeSH
- uteroglobin krev MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- srovnávací studie MeSH
BACKGROUND: Identification of serum and bronchoalveolar lavage fluid (BALF) biomarkers may facilitate diagnosis and prognostication in various lung disorders. OBJECTIVE: Serum and BALF levels of surfactant protein A (SP-A), surfactant protein D (SP-D), Clara cell protein 16 (CC16), S100 protein, trefoil factor 3 (TFF3), and prostatic secretory protein 94 (PSP94) were evaluated in 94 consecutive patients (idiopathic pulmonary fibrosis (IPF; n=18), sarcoidosis (n=25), chronic obstructive pulmonary disease (COPD; n=51)), and in 155 healthy controls. METHODS: Biomarkers were measured at diagnosis and compared with disease characteristics. Both uniparametric and multiparametric analyses were used. RESULTS: Seven significant correlations were found: 1) BALF PSP94 level correlated with prognosis of sarcoidosis (P=0.035); 2) BALF SP-D level with pulmonary functions in IPF (P=0.032); 3) BALF SP-D and TFF3 with IPF mortality (P=0.049 and 0.017, respectively); 4) serum TFF3 level with COPD mortality (P=0.006,); 5) serum SP-A with pulmonary functions impairment in IPF (P=0.011); 6) serum SP-D level was associated with HRCT interstitial score in IPF (P=0.0346); and 7) serum SP-A was associated with staging of COPD according to spirometry (P<0.001). Moreover, our analysis showed that some biomarker levels differed significantly among the diseases: 1) BALF SP-D level differed between sarcoidosis and IPF; 2) serum SP-A level differed among IPF, sarcoidosis, COPD and was also different from healthy controls; 3) serum S100A6, S100A11 levels differed among IPF, sarcoidosis, COPD from healthy controls 4) serum SP-D, CC16, TFF-3 levels distinguished IPF patients from healthy controls; and 5) serum CC16, TFF3, PSP94 distinguished COPD patients from healthy controls. Our study shows that some of selected biomarkers should have prognostic value in the analysed lung disorders. On the other hand, these biomarkers do not appear to be unequivocally suitable for differential diagnosis of these disorders.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013471
- 003
- CZ-PrNML
- 005
- 20170426093505.0
- 007
- ta
- 008
- 170413s2016 it f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)27758987
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Doubková, Martina $u Department of Pneumology, University Hospital, Jihlavska 20, 62500 Brno. doubkovamartina@seznam.cz.
- 245 10
- $a Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease / $c M. Doubková, M. Karpíšek, J. Mazoch, J. Skřičková, M. Doubek,
- 520 9_
- $a BACKGROUND: Identification of serum and bronchoalveolar lavage fluid (BALF) biomarkers may facilitate diagnosis and prognostication in various lung disorders. OBJECTIVE: Serum and BALF levels of surfactant protein A (SP-A), surfactant protein D (SP-D), Clara cell protein 16 (CC16), S100 protein, trefoil factor 3 (TFF3), and prostatic secretory protein 94 (PSP94) were evaluated in 94 consecutive patients (idiopathic pulmonary fibrosis (IPF; n=18), sarcoidosis (n=25), chronic obstructive pulmonary disease (COPD; n=51)), and in 155 healthy controls. METHODS: Biomarkers were measured at diagnosis and compared with disease characteristics. Both uniparametric and multiparametric analyses were used. RESULTS: Seven significant correlations were found: 1) BALF PSP94 level correlated with prognosis of sarcoidosis (P=0.035); 2) BALF SP-D level with pulmonary functions in IPF (P=0.032); 3) BALF SP-D and TFF3 with IPF mortality (P=0.049 and 0.017, respectively); 4) serum TFF3 level with COPD mortality (P=0.006,); 5) serum SP-A with pulmonary functions impairment in IPF (P=0.011); 6) serum SP-D level was associated with HRCT interstitial score in IPF (P=0.0346); and 7) serum SP-A was associated with staging of COPD according to spirometry (P<0.001). Moreover, our analysis showed that some biomarker levels differed significantly among the diseases: 1) BALF SP-D level differed between sarcoidosis and IPF; 2) serum SP-A level differed among IPF, sarcoidosis, COPD and was also different from healthy controls; 3) serum S100A6, S100A11 levels differed among IPF, sarcoidosis, COPD from healthy controls 4) serum SP-D, CC16, TFF-3 levels distinguished IPF patients from healthy controls; and 5) serum CC16, TFF3, PSP94 distinguished COPD patients from healthy controls. Our study shows that some of selected biomarkers should have prognostic value in the analysed lung disorders. On the other hand, these biomarkers do not appear to be unequivocally suitable for differential diagnosis of these disorders.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a bronchoalveolární lavážní tekutina $x chemie $7 D001992
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a idiopatická plicní fibróza $x krev $x diagnóza $x mortalita $7 D054990
- 650 _2
- $a plíce $x diagnostické zobrazování $x metabolismus $x patofyziologie $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a sekreční proteiny prostaty $x krev $7 D029584
- 650 _2
- $a chronická obstrukční plicní nemoc $x krev $x diagnóza $x mortalita $7 D029424
- 650 _2
- $a protein A asociovaný s plicním surfaktantem $x krev $7 D037662
- 650 _2
- $a protein D asociovaný s plicním surfaktantem $x krev $7 D037663
- 650 _2
- $a proteiny S100 $x krev $7 D009418
- 650 _2
- $a plicní sarkoidóza $x krev $x diagnóza $x mortalita $7 D017565
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a spirometrie $7 D013147
- 650 _2
- $a počítačová rentgenová tomografie $7 D014057
- 650 _2
- $a faktor TFF3 $x krev $7 D000071165
- 650 _2
- $a uteroglobin $x krev $7 D014598
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karpíšek, Michal
- 700 1_
- $a Mazoch, Jiri
- 700 1_
- $a Skřičková, Jana
- 700 1_
- $a Doubek, Michael
- 773 0_
- $w MED00177336 $t Sarcoidosis, vasculitis, and diffuse lung diseases official journal of WASOG $x 1124-0490 $g Roč. 33, č. 3 (2016), s. 224-234
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27758987 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170426093823 $b ABA008
- 999 __
- $a ok $b bmc $g 1199936 $s 974249
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 33 $c 3 $d 224-234 $e 20161007 $i 1124-0490 $m Sarcoidosis vasculitis and diffuse lung diseases $n Sarcoidosis Vasc Diffuse Lung Dis $x MED00177336
- LZP __
- $a Pubmed-20170413